The Ripple Effect: Investing in Life Sciences
The Ripple Effect: Investing in Life Sciences
Podcast Description
This limited podcast series, produced by GZERO’s Blue Circle Studios in partnership with Novartis, examines the unexpected ways that life sciences influence everything from national security to economic prosperity, to breakthroughs in other fields.
Podcast Insights
Content Themes
The podcast explores themes around the impact of life sciences on national security, economic resilience, and technological breakthroughs. Example episodes include discussions on the critical nature of biotechnological defenses against engineered viruses and the role of AI in enhancing lab automation and biosurveillance efforts.
This limited podcast series, produced by GZERO’s Blue Circle Studios in partnership with Novartis, examines the unexpected ways that life sciences influence everything from national security to economic prosperity, to breakthroughs in other fields.
Investing in health and science research isn’t just about curing diseases. It has huge impacts across society, from creating jobs to driving economic growth to boosting national competitiveness. Study shows that every $ invested in the life sciences industry generates $3 in GDP globally, whereas every job created in the life sciences industry generates five in the global economy. Life sciences are one of the most powerful engines of prosperity, yet many governments still underestimate their economic return.
In this episode of The Ripple Effect: Investing in Life Sciences, host Dan Riskin speaks with Patrick Horber, President of Novartis International, and David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. Together, they break down the outsized economic impact of life science innovation, from trillions in US bioscience output to China’s meteoric rise as a global R&D hub.
The conversation delves into the ways governments can support innovation with not just money, but through policy and regulation; plus, some of the best ways that countries can help the sector secure investment, talent, and long-term growth.
This limited series, produced by GZERO’s Blue Circle Studios in partnership with Novartis, examines how life science innovation plays a vital role in fulfilling that commitment.
Host: Dan Riskin
Guests: Patrick Horber, David Gluckman
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.